K25.ai Doubles Valuation to $200M in Amber-Backed Series A

K25.ai, a Singapore startup building AI-generated prediction markets on top of livestreams, closed a Series A round on July 23, 2026 with strategic backing from the digital-asset firm Amber Group, at a post-money valuation of $200 million. The company says that doubles its worth in under 60 days. It did not say how much it raised.

That last detail is the tell.

What K25.ai sells is a “watch-to-predict” platform: viewers of live sports, esports and entertainment streams wager on what happens next, with the company’s AI generating the markets, monitoring the feeds and resolving outcomes. Its founder and chief executive, Andy Cheung, was chief operating officer of the crypto exchange OKX and ran Groupon’s Hong Kong business before that. Cheung has pitched the product as “Twitch × Polymarket × ChatGPT.”

What the round doesn’t disclose

A financing that announces a valuation but no round size, no lead investor and no closing amount is selling a number rather than disclosing a deal. K25.ai described Amber Group’s involvement as “strategic support,” not as leading or pricing the round. The only investor comment came from Haoyu, a portfolio director at amber.ac, an Amber venture arm, and the release pointedly noted that such initiatives are “not necessarily attributable to” Amber International (AMBR ) Holding, the group’s Nasdaq-listed entity. The money, in other words, did not visibly come from the public company whose name lends the announcement its weight.

Amber Group itself is a real operator. Founded in 2017 and headquartered in Singapore, it runs digital-asset trading, market-making and infrastructure services, and it is a more credible name in the space than a repositioning fertility company. Which is the other half of this story.

A valuation set by a micro-cap

The Series A follows a Pre-A round that closed in June 2026 at a $100 million valuation, led by NewGenIVF Group Limited, a Nasdaq-listed company that committed $10 million for a roughly 10% stake. That backer rewards a second look. NewGenIVF started life as a fertility-clinic operator and has been recasting itself as a “diversified growth” company with a digital-asset treasury. Its own market capitalization was about $7.6 million in mid-June 2026 — less than the value of the stake it holds in K25.ai, and near the minimum market value Nasdaq wants listed companies to keep.

So the $100 million marker that K25.ai has now doubled was set by a company worth a fraction of the figure it validated. Cheung framed the Pre-A close as a defining milestone and promised a Series A at a step-up valuation; Amber Group’s arrival delivers it and adds a second institutional name to the cap table. In the latest announcement, Cheung said the backing “confirms the market is ready,” and that the company is “moving fast.”

K25.ai has floated bigger ambitions still. Alongside the Pre-A it said it might pursue a public listing, including through a reverse takeover — a route that fits neatly with a Nasdaq-listed backer that already holds a stake and board seats. For a company that has not shipped a product, talk of public markets is aggressive, and it explains the emphasis on serial valuation milestones, which are the currency such a path runs on.

A crowded market, a narrow footprint

Prediction markets are the hot corner of consumer fintech, and the competition is formidable. Polymarket and the U.S. exchange Kalshi, which struck a distribution deal with Robinhood, command the category at valuations far above K25.ai’s claimed $200 million. NewGenIVF, citing third-party data in its own announcements, has pointed to more than $458 billion in global prediction-market volume in 2025 and forecasts of $1 trillion by 2030 — the kind of numbers that make a pre-launch bet easier to underwrite.

The regulatory exposure is just as real. Prediction products routinely run into gambling, securities and derivatives rules, which is why K25.ai’s own limits matter: the platform is not offered to U.S. persons or to users in mainland China, Hong Kong or Macau, and the company says it will operate only where licensing allows. That is a narrower market than “AI meets live content” implies, and the product has not launched yet.

The round also lands in a hot AI funding market. Startups have kept closing sizeable rounds this summer, from Emergent’s $130 million Series C to Tsuga’s $35 million Series A. Both disclosed how much they raised. K25.ai did not.

For anyone tracking where AI capital is actually going, the signal here is modest. K25.ai has a credible founder, a genuinely interesting thesis and now two institutional backers. What it has not produced is a priced round, a named lead, a disclosed check or a shipped product, and a valuation that doubles in two months on strategic support rather than a competitive raise says more about how the number was set than about demand for the company. The test that matters is whether this Series A yields a live platform and a disclosed amount, not another valuation headline.